Respiratory infections remain the most common reason why patients seek medical care in
ambulatory and hospital settings, and they are the most frequent precursor of sepsis. In light …

Procalcitonin (PCT) is a peptide measurable in serum which becomes elevated in response
to bacterial infection. Multiple trials have explored the safety and efficacy of using PCT as a …

Objectives Procalcitonin (PCT) is a host-response biomarker that has shown clinical value
for assessing the likelihood of bacterial infections and guiding antibiotic treatment …

Circulating procalcitonin (PCT) is a biomarker that can be used in diagnosing bacterial
infections. We performed a quantitative meta-analysis of available randomized controlled …

Clinical signs of infection do not allow for correct identification of bacterial and viral aetiology
in acute respiratory infections. A valid tool to assist the clinician in identifying patients who …

Several controlled clinical studies have evaluated the potential of the infection biomarker
procalcitonin (PCT) to improve the diagnostic work-up of patients with bacterial infections …

Effective antimicrobial stewardship practices are increasingly essential to best utilize the
current arsenal of antimicrobials for the shortest necessary duration to minimize the …

Accumulating evidence supports procalcitonin (PCT) as an accurate surrogate biomarker for
likelihood and severity of bacterial infections. In community-acquired pneumonia and other …

Inclusion of PCT into antibiotic stewardship algorithms has the potential to improve the
diagnostic and therapeutic management of patients presenting with respiratory illnesses and …

Procalcitonin is a surrogate biomarker for estimating the likelihood of a bacterial infection.
Procalcitonin-guided initiation and termination of antibiotic therapy is a novel approach …